Olema Pharmaceuticals, Inc. (OLMA)
24.08
+0.27
(+1.13%)
USD |
NASDAQ |
Feb 20, 16:00
24.10
+0.02
(+0.08%)
After-Hours: 20:00
Olema Pharmaceuticals SG&A Expense (Quarterly) : 5.926M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 8.099M |
| Cogent Biosciences, Inc. | 23.93M |
| Corvus Pharmaceuticals, Inc. | 2.118M |
| BridgeBio Pharma, Inc. | 137.62M |
| Oric Pharmaceuticals, Inc. | 7.898M |